Edition:
United States

Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

69.71USD
2:22pm EST
Change (% chg)

$-0.92 (-1.30%)
Prev Close
$70.63
Open
$70.10
Day's High
$70.41
Day's Low
$69.69
Volume
463,114
Avg. Vol
1,022,569
52-wk High
$78.36
52-wk Low
$61.06

Chart for

About

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled... (more)

Overall

Beta: 0.70
Market Cap(Mil.): $34,277.83
Shares Outstanding(Mil.): 544.87
Dividend: 0.16
Yield (%): 1.02

Financials

  BAX.N Industry Sector
P/E (TTM): 38.37 32.17 33.71
EPS (TTM): 1.64 -- --
ROI: 6.78 13.75 14.48
ROE: 10.22 16.50 15.99

Smiths and ICU Medical healthcare merger talks collapse

British engineering firm Smiths Group Plc said on Thursday talks with U.S.-based ICU Medical Inc over a possible 7 billion pound-plus ($9.2 billion) merger of their healthcare businesses had fallen through.

Sep 13 2018

UPDATE 1-Smiths Group, ICU Medical close to abandoning healthcare merger -Sky News

Aug 7 British engineering firm Smiths Group Plc is close to abandoning talks with U.S.-based ICU Medical Inc over a 7 billion pound ($9 billion) merger of their healthcare divisions, Sky News reported on Monday.

Aug 07 2018

Earnings vs. Estimates